2.1 USD
0 (0%)
AMS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AMS have multiple concerns. AMS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- AMS had negative earnings in the past year.
- In the past year AMS had a positive cash flow from operations.
- Of the past 5 years AMS 4 years were profitable.
- Each year in the past 5 years AMS had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -3.84%, AMS is not doing good in the industry: 64.08% of the companies in the same industry are doing better.
- AMS has a Return On Equity (-9.97%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.84% | ||
| ROE | -9.97% | ||
| ROIC | N/A |
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AMS's Profit Margin has improved in the last couple of years.
- AMS's Operating Margin has declined in the last couple of years.
- AMS has a Gross Margin of 24.43%. This is comparable to the rest of the industry: AMS outperforms 51.46% of its industry peers.
- AMS's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for AMS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.43% |
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
- AMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AMS has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AMS has more shares outstanding
- The debt/assets ratio for AMS is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.85, we must say that AMS is in the distress zone and has some risk of bankruptcy.
- AMS has a worse Altman-Z score (0.85) than 73.79% of its industry peers.
- A Debt/Equity ratio of 0.58 indicates that AMS is somewhat dependend on debt financing.
- AMS has a Debt to Equity ratio of 0.58. This is comparable to the rest of the industry: AMS outperforms 59.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.85 |
ROIC/WACCN/A
WACC9.45%
2.3 Liquidity
- AMS has a Current Ratio of 1.17. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.
- AMS's Current ratio of 1.17 is in line compared to the rest of the industry. AMS outperforms 41.75% of its industry peers.
- AMS has a Quick Ratio of 1.17. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.17, AMS is in line with its industry, outperforming 47.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- The earnings per share for AMS have decreased strongly by -950.00% in the last year.
- AMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.28% yearly.
- The Revenue has grown by 32.90% in the past year. This is a very strong growth!
- The Revenue has been growing slightly by 6.58% on average over the past years.
EPS 1Y (TTM)-950%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%100%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%2.46%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y44.91%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.01%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- AMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year AMS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AMS is valued cheaply inside the industry as 96.12% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.49 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- AMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMERICAN SHARED HOSPITAL SER / AMS FAQ
What is the fundamental rating for AMS stock?
ChartMill assigns a fundamental rating of 2 / 10 to AMS.
What is the valuation status of AMERICAN SHARED HOSPITAL SER (AMS) stock?
ChartMill assigns a valuation rating of 1 / 10 to AMERICAN SHARED HOSPITAL SER (AMS). This can be considered as Overvalued.
How profitable is AMERICAN SHARED HOSPITAL SER (AMS) stock?
AMERICAN SHARED HOSPITAL SER (AMS) has a profitability rating of 3 / 10.
What is the earnings growth outlook for AMERICAN SHARED HOSPITAL SER?
The Earnings per Share (EPS) of AMERICAN SHARED HOSPITAL SER (AMS) is expected to grow by 44.91% in the next year.